Compassionate Use of Remdesivir for Patients with Severe Covid-19
暂无分享,去创建一个
Erwan L'Her | Alexander Zoufaly | Marco Massari | Sumit Majumder | Shingo Chihara | Norio Ohmagari | Jennifer Cunningham | A. d’Arminio Monforte | M. Massari | A. Chokkalingam | E. Nicastri | A. Zoufaly | T. Flanigan | M. L. Green | E. L’her | A. Gaggar | R. Childs | N. Ohmagari | Duc Minh Nguyen | F. Lescure | Scott V. Sellers | D. Brainard | Lijie Zhong | George A. Diaz | R. Mera | Stuart H. Cohen | R. Myers | T. Feldt | A. Osinusi | François-Xavier Lescure | Robert P Myers | Emanuele Nicastri | H. Cao | J. Grein | Daniel Shin | E. Asperges | A. Castagna | Gary M Green | Rentaro Oda | Kikuo Yo | E. Quiros-Roldan | A. Studemeister | John Redinski | Seema Ahmed | J. Bernett | D. Chelliah | Danny Chen | S. Chihara | J. Cunningham | S. Ismail | H. Kato | G. Lapadula | T. Maeno | Sumit Majumder | M. Mora-Rillo | Y. Mutoh | E. Verweij | A. DeZure | Yang Zhao | E. Elboudwarej | L. Telep | Leighann Timbs | Ilana N. Henne | Susanna K. Tan | Lucinda Winterbourne | P. Desai | Anand Chokkalingam | Stuart H Cohen | Antonella D'Arminio Monforte | Antonella Castagna | Eugenia Quiros-Roldan | Lijie Zhong | Timothy Flanigan | Diana M Brainard | Giuseppe Lapadula | Adam DeZure | Jonathan Grein | Daniel Shin | George Diaz | Erika Asperges | Torsten Feldt | Gary Green | Margaret L Green | Rentaro Oda | Kikuo Yo | Alex Studemeister | John Redinski | Seema Ahmed | Jorge Bernett | Daniel Chelliah | Danny Chen | Saad Ismail | Hideaki Kato | Toshitaka Maeno | Marta Mora-Rillo | Yoshikazu Mutoh | Duc Nguyen | Ewa Verweij | Anu O Osinusi | Yang Zhao | Emon Elboudwarej | Laura Telep | Leighann Timbs | Ilana Henne | Scott Sellers | Huyen Cao | Susanna K Tan | Lucinda Winterbourne | Polly Desai | Robertino Mera | Anuj Gaggar | Richard Childs | G. Diaz | Gary M. Green | Duc Nguyen
[1] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[2] S. Lindstrom,et al. First Case of 2019 Novel Coronavirus in the United States , 2020, The New England journal of medicine.
[3] A. Davis,et al. Management of Critically Ill Adults With COVID-19. , 2020, JAMA.
[4] T. West,et al. Covid-19 in Critically Ill Patients in the Seattle Region — Case Series , 2020, The New England journal of medicine.
[5] Jing Yuan,et al. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. , 2020, JAMA.
[6] Xavier Duval,et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series , 2020, The Lancet Infectious Diseases.
[7] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[8] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[9] H. Feldmann,et al. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection , 2020, Proceedings of the National Academy of Sciences.
[10] Alfonso J. Rodriguez-Morales,et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis , 2020, Travel Medicine and Infectious Disease.
[11] E. Rubin,et al. Covid-19 — The Search for Effective Therapy , 2020, The New England journal of medicine.
[12] D. Cucinotta,et al. WHO Declares COVID-19 a Pandemic , 2020, Acta bio-medica : Atenei Parmensis.
[13] Xin Zhou,et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.
[14] X. de Lamballerie,et al. Of chloroquine and COVID-19 , 2020, Antiviral Research.
[15] Chao Zhang,et al. Liver injury in COVID-19: management and challenges , 2020, The Lancet Gastroenterology & Hepatology.
[16] D. Murdoch,et al. Clinical course and mortality risk of severe COVID-19 , 2020, The Lancet.
[17] A. Spinelli,et al. COVID-19 pandemic: perspectives on an unfolding crisis , 2020, The British journal of surgery.
[18] Sharukh Lokhandwala,et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. , 2020, JAMA.
[19] R. Baric,et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV , 2020, Nature Communications.
[20] R. Redfield,et al. Covid-19 — Navigating the Uncharted , 2020, The New England journal of medicine.
[21] Catherine M. Brown,et al. First 12 patients with coronavirus disease 2019 (COVID-19) in the United States , 2020, medRxiv.
[22] Yuan Wei,et al. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 , 2020, The New England journal of medicine.
[23] G. Onder,et al. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. , 2020, JAMA.
[24] Lisa E. Gralinski,et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses , 2017, Science Translational Medicine.
[25] Wu Zhong,et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro , 2020, Cell Research.
[26] Michael Proschan,et al. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics. , 2019, The New England journal of medicine.